rose 14% as the company continued to recover from a big loss to start the week. On Monday, its shares tumbled roughly 60% after its heart disease drug failed to meet the main target of a phase III trial. The stock was recently adding 45 cents to $3.67.
Adams Respiratory Therapeutics
was also surging after the company said it has settled a patent lawsuit over a generic version of Mucinex with Mutual Pharmaceutical and United Research Laboratories. Recently, Adams was climbing $5.17, or 16.8%, to $36.01.
On the downside,
dropped 5.1% after the drugmaker's fourth-quarter loss swelled from the same quarter in the previous year. The stock was off 24 cents at $4.48.
Elsewhere, JPMorgan reduced both
to underweight from neutral. GlaxoSmithKline was off 1.4% at $55.44, and AstraZeneca was down 1.3% at $55.95.
Also on the move,
was up 7.6% at $10.32.
was rising 4.2% at $34.
was gaining 2.4% to $12.44.
was off 2.2% at $53.42.
St. Jude Medical
was recently down 1% to $37.99.